[ET Net News Agency, 18 November 2019] CSPC Pharmaceutical Group Limited (01093) said
its profit attributable to owners of the company was RMB2.81 billion for the nine months
ended 30 September 2019, a year-on-year increase of 24%. The basic earnings per share were
RMB45.15 cents. No dividend will be distributed.
The revenue was RMB16.76 billion, a year-on-year increase of 27.5%. The gross profit was
RMB11.89 billion, a year-on-year increase of 38.7%. (RC)